SYMPOSIA
EADV 2022
Reimagining immunology: The path to optimized management of chronic spontaneous urticaria
M. Maurer, S. Ferrucci and S. F. Thomsen
Symposia
Welcome and introduction
M. Maurer
The path to optimized management of chronic spontaneous urticaria
M. Maurer, S. Ferrucci and S. F. Thomsen
Q&A
M. Maurer, S. Ferrucci and S. F. Thomsen
EAACI 2022
SlidesWelcome & Introduction
M. Maurer
Chronic Spontaneous Urticaria: defining the pathway to successful management
A panel discussion on overcoming roadblocks to CSU care, based on real life experiences
M. Maurer, E. Kocatürk and S. Savic
Live Q&A
M. Maurer, E. Kocatürk and S. Savic
EADV 2021
The patient journey in CSU: The challenges we face
A. M. Giménez-Arnau
Optimizing patient outcomes in CSU: Could new biologics help achieve this?
R. Saini
Exploring novel pathways in the journey to complete CSU control
J. Reed
EAACI 2021
Why do our patients fail to reach complete control?
Z. Brzoza
How can targeting IgE contribute to complete control?
M. Maurer
EAACI 2020
IgE inhibition implications: How does this benefit patients with chronic spontaneous urticaria?
M. Maurer
EADV 2020
Redefining patient care in chronic spontaneous urticaria
M. Maurer, A. Giménez-Arnau, A. Eggel
